Feedback / Questions
ibrilatazar (ABTL0812) - Ability Pharma
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-024-12501-5
Jul 22, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next